Director Mats Wahlstrom sold $2.4M of Coherus Oncology, Inc.

Sold$2,375,409

$20.12Price

118,066Shares

−37%Stake

What CHRS did after the filing

Prices for CHRS after this filing aren't in yet.

Traded Tue, Mar 3. Filed Thu, Mar 5, 11:31 AM ET, during the session. Not investment advice.